Argus analyst Chris Graja raised the firm’s price target on Procter & Gamble to $185 from $180 and keeps a Buy rating on the shares. The analyst cites the company’s Q3 earnings beat while noting that its innovative products have allowed Procter & Gamble to raise prices to offset inflation, even as some customers trade down to store brands or to less expensive brands within the P&G portfolio. The firm is also positive on the company’s record of dividend growth, noting that the management’s 7% dividend hike in April showed confidence in future performance.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Procter & Gamble price target raised to $170 from $168 at Barclays
- Procter & Gamble price target lowered to $171 from $172 at Deutsche Bank
- Procter & Gamble price target raised to $178 from $175 at Raymond James
- Procter & Gamble price target raised to $177 from $175 at Evercore ISI
- Procter & Gamble price target raised to $182 from $175 at Jefferies
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue